Vista Pharmaceuticals Ltd.

VISTAPH

₹10.34

-3.27% (-0.35)

Market Cap

₹61 Cr.

P/E

0.00

Key Ratios

Edit Ratio's

Market cap

61.00 Cr

Prom Holding

21.19 %

ROE (%)

-11.15

ROCE (%)

-9.79

Div Yield (%)

Sales

10.07 Cr

OPM (%)

-39.99 %

Debt to Equity

0.22

Edit Ratio's

About

Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmac… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

4 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
ROE

Roe has decreased vs 10 year trend
Share price

Share price has decreased over last 10 years more due to derating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Vista Pharmaceuticals Ltd. Business

What does Vista Pharma do?

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations, including a range of generic drug products. Founded in 1992 with a vision to expand globally.

Who are the competitors of Vista Pharma?

Vista Pharma major competitors are Shanmuga Hospital, Medicamen Organics, Godavari Drugs, Vivo Bio Tech, Shelter Pharma, JFL Life Sciences, Lasa Supergenerics.
Market Cap of Vista Pharma is ₹61 Crs.
While the median market cap of its peers are ₹53 Crs.

Is Vista Pharma financially stable compared to its competitors?

Vista Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Vista Pharma is 3.33 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Vista Pharmaceuticals Ltd.

Vista Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

4 Yes

2 Neutral

9 No

2 No Data

Accounting & Shareholding

Other Income

Pledge

Revenue Recognition

Depreciation Effect

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

Balance Sheet Strength

Capex vs ROCE

Debt

ROE

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Vista Pharma do?

Who are the competitors of Vista Pharma?

Is Vista Pharma financially stable compared to its competitors?

SIGN UP FOR FREE